Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019024518) DRUG FOR TREATING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) INVOLVED DISEASE BY ADJUSTING PHOSPHORYLATION OF YB-1
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/024518 International Application No.: PCT/CN2018/080675
Publication Date: 07.02.2019 International Filing Date: 27.03.2018
IPC:
A61K 45/00 (2006.01) ,A61P 35/00 (2006.01) ,A61P 37/00 (2006.01) ,A61P 25/08 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
08
Antiepileptics; Anticonvulsants
Applicants:
吉林众泰生物技术有限公司 JILIN ZHONGTAI BIOTECHNOLOGICAL COMPANY LIMITED [CN/CN]; 中国吉林省长春市 经济技术开发区东南湖大路1055号 No. 1055 Dongnanhu Road, Economic and Technological Development Area Changchun, Jilin 130000, CN
Inventors:
刘斌 LIU, Bin; CN
Agent:
北京海虹嘉诚知识产权代理有限公司 HAIHONG JIACHENG INTELLECTUAL PROPERTY & PARTNERS; 中国北京市 海淀区海淀南路21号中关村知识产权大厦B座9层 9th Floor, Tower B, Zhongguancun Intellectual Property Mansion No.21, South Road HaiDian, Haidian District Beijing 100080, CN
Priority Data:
201710657706.903.08.2017CN
201810175137.902.03.2018CN
Title (EN) DRUG FOR TREATING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) INVOLVED DISEASE BY ADJUSTING PHOSPHORYLATION OF YB-1
(FR) MÉDICAMENT POUR LE TRAITEMENT D'UNE MALADIE IMPLIQUANT LA PROTÉINE CHIMIOATTRACTIVE DES MONOCYTES DE TYPE 1 (MCP-1) PAR AJUSTEMENT DE LA PHOSPHORYLATION DE YB-1
(ZH) 通过调控YB-1磷酸化治疗MCP-1参与的疾病的药物
Abstract:
(EN) Provided is a drug for treating a MCP-1 involved disease. The drug sets YB-1 as a drug target, and the active components thereof comprise a substance that can directly or indirectly adjust phosphorylation of YB-1.
(FR) L'invention concerne un médicament pour le traitement d'une maladie impliquant la MCP-1. Les ensembles médicamenteux YB-1 à titre de cibles médicamenteuses, et leurs principes actifs, comprennent une substance qui peut directement ou indirectement ajuster la phosphorylation de YB-1.
(ZH) 提供一种用于治疗单核细胞趋化蛋白-1参与的疾病的药物,所述药物以YB-1为药物靶点,并且其活性成分包括能直接或间接调控YB-1磷酸化的物质。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)